B · Normal
On November 12, Hungarian pharmaceutical company Gilead (Richter) signed a women's health drug licensing agreement with Eli Lilly.
Related telegraphs
[Yunnan: Explore the development of “TCM + AI” and promote the application of TC
11-12 11:47
[Fujian: Build 10 artificial intelligence scientific research and innovation pla
11-12 11:25
[Brokerage research becomes more popular in November, favoring electronics, mech
11-12 07:29
[Listed companies’ “chain” efforts to deeply participate in industrial M&A funds
11-12 07:22
[Eli Lilly announced new data on the combination treatment of Taltz and Zepbound
11-11 22:48
On November 11th, Novo Nordisk committed to investing US$200 million within 10 y
11-11 17:32
Comments